Personalised Medicine (PerMed) opens unexplored frontiers to treat diseases at the individual level combining clinical and omics information. However, the performances of the current simu

Aims to develop a solution able to support the digital transformation of European industry by providing an optimized, highly resilient heterogeneous execution environment enabling